Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Juvenile Idiopathic Arthritis: full-pipeline trial registry
3 of 9 indexed Juvenile Idiopathic Arthritis trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Juvenile Idiopathic Arthritis: 9 US clinical trials tracked, 3 recruiting.
Juvenile Idiopathic Arthritis is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is AbbVie, running 2 of these trials.
Enrollment posture brief
Registry condition juvenile-idiopathic-arthritis
OPEN 3 | RECR 33% | LATE 3 | EARLY 2 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Juvenile Idiopathic Arthritis lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Juvenile Idiopathic Arthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Juvenile Idiopathic Arthritis is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Juvenile Idiopathic Arthritis research.
AbbVie accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Juvenile Idiopathic Arthritis enrolment sits around 90 participants.
Median target enrolment is 90 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Juvenile Idiopathic Arthritis splits between interventional and observational designs.
6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Pain in Juvenile Arthritis
Washington University School of Medicine
NCT07217782
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
AbbVie
NCT05609630
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Children's National Research Institute
NCT04833465
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Bristol-Myers Squibb
NCT01357668
Juvenile Idiopathic Arthritis (JIA) Registry
AbbVie
NCT00783510
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
Pfizer
NCT01500551
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Seattle Children's Hospital
NCT00443430
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Hoffmann-La Roche
NCT01904292
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Amgen
NCT01563185
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Juvenile Idiopathic Arthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Juvenile Idiopathic Arthritis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Juvenile Idiopathic Arthritis page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Juvenile Idiopathic Arthritis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AbbVie sponsors the most Juvenile Idiopathic Arthritis trials on record, review their full trial history before evaluating a specific study. See AbbVie's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Juvenile Idiopathic Arthritis condition card totals 9 registered trials; most-linked intervention Tocilizumab; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.